Stock listing
Thiogenesis Therapeutics Corp
Selected listing: Q8M · FWB · EUR · DE
Thiogenesis Therapeutics Corp (Frankfurt:Q8M), Finance. Latest release Sep 21, 2026: Thiogenesis Reports Results of 2026 Annual and Special Meeting…
- Ticker
- Frankfurt:Q8M
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- Frankfurt
- Currency
- EUR
About Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp (Ticker: TTI) is a public company based in Canada, focused on developing innovative therapeutic solutions. Thiogenesis is dedicated to advancing its research and development efforts to address unmet medical needs.
Latest news from Thiogenesis Therapeutics Corp
Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update
September 21, 2026
Thiogenesis Engages Brisco Capital for Investor Relations
September 3, 2026
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
July 13, 2026
Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors
June 17, 2026
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
June 3, 2026
Research Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp company profile
View the public company page for Thiogenesis Therapeutics Corp on 6ix.
Thiogenesis Therapeutics Corp news
Read company news and market updates connected to Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics Corp investor events
Find investor webinars, events, and replay context for Thiogenesis Therapeutics Corp.
Alternate listings
TTI:TSXV
CA · CAD
Alternate listing for Thiogenesis Therapeutics Corp; the primary context on this page is Q8M:FWB.
TTIPF:OTC
US · USD
Alternate listing for Thiogenesis Therapeutics Corp; the primary context on this page is Q8M:FWB.
TTI:NEO
CA · CAD
Alternate listing for Thiogenesis Therapeutics Corp; the primary context on this page is Q8M:FWB.